Otitis can be a challenging condition to manage in canine patients, so recognizing common compliance challenges can help ...
The FDA has approved 2 additional vial sizes of Niktimvo™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback